Micropulsed Diode Laser Therapy: Evolution and Clinical Applications

Survey of Ophthalmology

Volumn 55, Issue 6, 2010, Pages 516-530

  Sivaprasad, Sobha ^a   Elagouz, Mohammed ^a,b   McHugh, Dominic ^a   Shona, Olajumoke ^a   Dorin, Giorgio ^c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b Sohag University   (Egypt)

^c IRIDEX Corporation   (United States)

Author keywords

Central serous chorioretinopathy; Diabetic macular edema; Glaucoma; Laser; Micropulse diode laser; Subthreshold laser photocoagulation

Indexed keywords

CENTRAL SEROUS RETINOPATHY; CLINICAL TRIAL; COLOR VISION DEFECT; CONTRAST SENSITIVITY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DIODE LASER; EVIDENCE BASED MEDICINE; HUMAN; LASER COAGULATION; LASER SURGERY; MICROPULSED DIODE LASER THERAPY; NIGHT VISION; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PIGMENT EPITHELIUM; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RETINA INJURY; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SPECTRAL SENSITIVITY; TEMPERATURE SENSITIVITY; THERAPY EFFECT; TISSUE INTERACTION; TRABECULOPLASTY; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

ANIMALS; HUMANS; LASER COAGULATION; LASERS, SEMICONDUCTOR; RETINAL DISEASES;

EID: 77957753652     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2010.02.005     Document Type: Review

References (88)

1. Akduman L., Olk R.J. Subthreshold (invisible) modified grid diode laser photocoagulation in diffuse diabetic macular edema (DDME). Ophthalmic Surg Lasers 1999, 30(9):706-714.
2. Balles M.W., Agarwal A. Exposure time dependent variation in diode laser energy required for retinal photocoagulation [ARVO abstract no. 1276]. Invest Ophthalmol Vis Sci 1993, 34(4):S961.
3. Balles M.W., Puliafito C.A., D'Amico D.J., et al. Semiconductor diode laser photocagulation in retinal vascular disease. Ophthalmology 1990, 97:1553-1561.
4. Bandello F., Brancato R., Menchini U., et al. Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy. Semin Ophthalmol 2001, 16(1):12-18.
5. Barnstable C.J., Tombran-Tink J. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential. Prog Ret Eye Res 2004, 23(5):561-577.
6. Birch J., Hamilton A.M. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 2. Effect on colour vision. Trans Ophthalmol Soc UK 1981, 101:93-99.
7. Blumenkranz M.S., Yellachich D., Andersen D.E., et al. Semiautomated patterned scanning laser for retinal photocoagulation. Retina 2006, 26(3):370-376.
8. Brancato R., Pratesi R., Leoni G., et al. Histopathology of diode and argon lasers in rabbit retina. Invest Ophthalmol Vis Sci 1989, 30(7):1504-1510.
9. Brancato R., Partesi R. Applications of diode lasers in Ophthalmology. Lasers Light Ophthalmol 1987, 1:119.
10. Cardillo J.A., Lavinsky D., Mello L., et al. Comparison of the modified ETDRS and normal or high density subthreshold infrared micropulsed laser photocoagulation strategies for diabetic macular edema. Invest Ophthalmolmol Vis Sci 2008, 49. ARVO E-Abstract 1566.
11. Cardillo P.F., Eandi C.M., Ventre L., et al. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003, 23:752-763.
12. Chan W.M., Lam D.S., Lai T.Y., et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003, 87:1453-1458.
13. Chen S.N., Hwang J.F., Tseng L.F., Lin C.J. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology 2008, 115(12):2229-2234.
14. Clover G.M. The effects of argon and krypton photocoagulation on the retina: implication for the inner and outer blood retinal barriers. Laser Photocoagulation of Retinal Disease. From the International Laser Symposium 1988, 11-17. Pacific Medical Press, San Francisco, CA. G. Gitter (Ed.).
15. Detry-Morel M., Muschart F., Pourjavan S. Micropulse diode laser (810 nm) versus argon laser trabeculoplasty in the treatment of primary open-angle glaucoma: comparative short-term safety and efficacy profile. Bull Soc Belge Ophthalmol 2008, 308:21-28.
16. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976, 81:383-396. Diabetic Retinopathy Study Research Group.
17. Dorin G. Evolution of retinal laser therapy: minimum intensity photocoagulation (MIP). Can the laser heal the retina without harming it?. Semin Ophthalmol 2004, 19(1-2):62-68.
18. Dorin G. Subthreshold and micropulse diode laser photocoagulation. Semin Ophthalmol 2003, 18(3):147-153.
19. Early photocoagulation for diabetic retinopathy: ETRDS report number 9. Ophthalmology 1991, 98:S766-S785. Early Treatment Diabetic Retinopathy Study Research Group.
20. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 1. Arch Ophthalmol 1985, 103:1796-1806. Early Treatment Diabetic Retinopathy Study Research Group.
21. Fea A.M., Bosone A., Rolle T., et al. Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up. Clin Ophthalmol 2008, 2(2):247-252.
22. Figueira C., Khan J., Nunes S., et al. Prospective randomized controlled trial comparing subthreshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol 2009, 93(10):1341-1344.
23. Framme C., Schüle G., Roider J., et al. Online autofluorescence measurements during selective RPE laser treatment. Graefes Arch Clin Exp Ophthalmol 2004, 242(10):863-869.
24. Friberg T.R., Karatza E.C. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology 1997, 104:2030-2038.
25. Fudemberg S.J., Myers J.S., Katz L.J. Trabecular meshwork tissue examination with scanning electron microscopy: a comparison of micropulse diode laser (MLT), selective laser (SLT), and argon laser (ALT) trabeculoplasty in human cadaver tissue. Invest Ophthalmol Vis Sci 2008, 49. E-abstract 1236.
26. Glaser B.M., Campochiaro P.A., Davis J.L., et al. Retinal pigment epithelial cells release inhibitors of neovascularization. Ophthalmology 1987, 94:780-784.
27. Goebel W., Pfeiffer N., Grehn F. Patient discomfort during laser treatment, a comparison between diode and argon laser [ARVO abstract]. Invest Ophthalmol Vis Sci 1994, 35(Supp):553.
28. Greiss G.A., Blankenstein M.F. Multiple-pulse laser retinal damage thresholds. Am Ind Hyg Assoc J 1981, 42:287-292.
29. Ham W.T., Mueller H.A., Wolbarsht M.L., et al. Evaluation of retinal exposures from repetitively pulsed and scanning lasers. Health Phys 1988, 54:337-344.
30. Hattenbach L.O., Beck K.F., Pfeilschifter J., et al. Pigment-epithelium-derived factor is upregulated in photocoagulated human retinal pigment epithelial cells. Ophthalmic Res 2005, 37(6):341-346.
31. Iliusi F.G., Preda M. The adaptometry study in patients with diabetic retinopathy. Oftalmologia 2004, 48:43-47.
32. Jain A., Blumenkranz M.S., Paulus Y., et al. Effect of pulse duration on size and character of the lesion in retinal photocoagulation. Arch Ophthalmol 2008, 126(1):78-85.
33. Khosla P.K., Rao V., Tewari H.K., et al. Contrast sensitivity in diabetic retinopathy after panretinal photocoagulation. Ophthalmic Surg 1994, 25:516-520.
34. Kim S.Y., Sanislo S.R., Dalal R., et al. The selective effect of micropulse diode laser upon the retina [ARVO abstract no. 3584]. Invest Ophthalmol Vis Sci 1996, 37(3):S779.
35. Lanzetta P., Dorin G., Piracchio A., et al. Theoretical bases of non-ophthalmoscopically visible endpoint photocoagulation. Semin Ophthalmol 2001, 16(1):8-11.
36. Lanzetta P., Furlan F., Morgante L., et al. Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur J Ophthalmol 2008, 18(6):934-940.
37. Lanzetta P., Menchini U., Virgili G. Immediate intraocular pressure response to selective laser trabeculoplasty. Br J Ophthalmol 1999, 83:29-32.
38. Lanzetta P., Polito A., Veritti D. Subthreshold laser. Ophthalmology 2008, 115(1):216.
39. Laursen M.L., Moeller F., Sander B., et al. Subthreshold micropulse diode laser treatment in diabetic macular oedema. Br J Ophthalmol 2004, 88:1173-1179.
40. Lovestam-Adrian M., Svendenius N., Agardh E. Contrast sensitivity and visual recovery time in diabetic patients treated with panretinal photocoagulation. Acta Ophthalmol Scand 2000, 78:672-676.
41. Ludwig K., Lasser T., Sakowski H., et al. Photocoagulation in the edematous and non-edematous retina with the CW laser of different wavelength. Ophthalmologe 1994, 91:783-788.
42. Luttrull J.K., Musch D.C., Mainster M.A. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol 2005, 89:74-80.
43. Luttrull J.K., Musch D.C., Spink C.A. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy. Eye 2008, 22:607-612.
44. Luttrull J.K., Spink C.J. Serial optical coherence tomography of subthreshold diode laser micropulse photocoagulation for diabetic macular edema. Ophthalmic Surg Lasers Imaging 2006, 37:370-377.
45. Mainster M.A., Sliney D.H., Belcher C.D., et al. Laser photodisruptors. Damage mechanisms, instrument design and safety. Ophthalmology 1983, 90(8):973-991.
46. Mainster M.A., White T.J., Allen R.G. Spectral dependance of retinal damage produced by intense light sources. J Opt Soc AM 1970, 60:848-855.
47. Mainster M.A., White T.J., Tips J.H., et al. Retinal temperature increases produced by intense light sources. J Opt Soc AM 1970, 60:264-270.
48. Mainster M.A., White T.J., Tips J.H., et al. Transient thermal behaviour in biological systems. Bull Math Biophys 1970, 32:303-314.
49. Mainster M.A. Decreasing retinal photocoagulation damage: principles and techniques. Semin Ophthalmol 1999, 14(4):200-209.
50. Mainster M.A. Ophthalmic laser surgery: principles, technology and technique. Symposium on the Laser in Ophthalmology and Glaucoma Update: New Orleans Acad Ophthalmol 1985, CV Mosby, St Louis, MO, pp 81-101.
51. Mainster M.A. Wavelength selection in macular photocoagulation: tissue optics, thermal effects and laser systems. Ophthalmology 1986, 93:952-958.
52. McHugh D., Marshall J., ffytche T.J., et al. Initial clinical experience using a diode laser in the treatment of retinal vascular disease. Eye 1989, 3:516-527.
53. McHugh J.D.A., Marshall J., Capon M., et al. Transpupillary retinal photocoagulation in the eyes of rabbit and human using a diode laser. Lasers Light Ophthalmol 1988, 2:125-143.
54. McHugh J.D.A., Marshall J., ffytche T.J., et al. Macular photocoagulation with a diode laser: a comparative histopathological study. Lasers Light Ophthalmol 1990, 3:11-28.
55. Vujosevic S., Bottega E., Casciano M., et al. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina 2010, 30(6):908-916.
56. Miller H., Miller B., Ryan S.J. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci 1986, 27:1644-1652.
57. Moorman C.M., Hamilton A.M.P. Clinical applications of the micropulse diode laser. Eye 1999, 13:145-150.
58. Moriarty A.P., McHugh J.D., Ffytche T.J., et al. Long-term follow-up of diode laser trabeculoplasty for primary open-angle glaucoma and ocular hypertension. Ophthalmology 1993, 100(11):1614-1618.
59. Moriarty A.P., McHugh J.D., Spalton D.J., et al. Comparison of the anterior chamber inflammatory response to diode and argon laser trabeculoplasty using a laser flare meter. Ophthalmology 1993, 100(8):1263-1267.
60. Obana A., Lorenz B., Gassler A., et al. The therapeutic range of chorioretinal photocoagulation with diode and argon lasers: an experimental comparison. Lasers Light Ophthalmol 1992, 4:147-156.
61. Ogata N., Tombran-Tink J., Jo N., et al. Upregulation of pigment epithelium-derived factor after laser photocoagulation. Am J Ophthalmol 2001, 132(3):427-429.
62. Pahor D. Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full- versus mild-scatter coagulation. Int Ophthalmol 1998, 22:313-319.
63. Pankratov M.M. Pulsed delivery of laser energy in experimental thermal retinal photocoagulation. Proc Soc Photo-Optical Instrum Eng 1990, 1202:205-213.
64. Parodi B.M., Iacono P., Ravalico G. Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular edema in branch retinal vein occlusion: a pilot study. Br J Ophthalmol 2008, 92:1046-1050.
65. Parodi B.M., Spasse S., Iacono P., et al. Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology 2006, 113:2237-2242.
66. Pollack J.S., Kim J.E., Pulido J.S., et al. Tissue effects of subclinical diode laser treatment of the retina. Arch Ophthalmol 1998, 116:1633-1639.
67. Prskavec F.H., Fulmek R., Klemen C., et al. Changes in the visual field and dark adaptation following panretinal photocoagulation in diabetic retinopathy. Klin Monatsbl Augenheilkd 1986, 189:385-387.
68. Ricci F., Missiroli F., Cerulli L. Indocyanine green dye-enhanced micropulsed diode laser: a novel approach to subthreshold RPE treatment in a case of central serous chorioretinopathy. Eur J Ophthalmol 2004, 14(1):74-82.
69. Ricci F., Missiroli F., Regine F., et al. Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2009, 247(5):597-607.
70. Roider J., Brinkmann R., Wirbelauer C., et al. Variability of RPE reaction in two cases after selective RPE laser effects in prophlactic treatment of drusen. Graefes Arch Clin Exp Ophthalmol 1999, 237:45-50.
71. Roider J., Hillenkamp F., Flotte T., et al. Microphotocoagulation: selective effects of repetitive short laser pulses. Proc Natl Acad Sci 1993, 90:8643-8647.
72. Roider J., Lindemann C., el-Hifnawi el-S., et al. Therapeutic range of repititive nanosecond laser exposures in selective RPE photocoagulation. Graefes Arch Clin Exp Ophthalmol 1998, 236:213-219.
73. Roider J., Michaud N., Flotte T.J., et al. Microcoagulation of the fundus. Experimental results of repeated laser pulse exposure. Fortschr Ophthalmol 1991, 88:473-476.
74. Roider J., Michaud N., Flotte T.J., et al. Response of the retinal pigment epithelium to selective photocoagulation. Arch Ophthalmol 1992, 110:1786-1792.
75. Ruskovic D., Boulton M., Ulbig M.W., et al. The effect of micropulsed diode laser on human RPE in vivo and in vitro [ARVO abstract no. 3483]. Invest Ophthalmol Vis Sci 1997, 38(4):S754.
76. Russell P.W., Sekuler R., Fetkenhour C. Visual function after panretinal photocoagulation: a survey. Diabetes Care 1985, 8:57-63.
77. Schuele G., Rumohr M., Huettmann G., et al. RPE damage thresholds and mechanisms for laser exposure in the microsecond-to-millisecond time regimen. Invest Ophthalmol Vis Sci 2005, 46(2):714-719.
78. Seiberth V., Alexandridis E. Function of the diabetic retina after panretinal argon laser photocoagulation. Influence of the intensity of the coagulation spots. Ophthalmologica 1991, 202:10-17.
79. Sivaprasad S., Sandhu R., Tandon A., et al. Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-year follow-up. Clin Exper Ophthalmol 2007, 35(7):640-644.
80. Sliney D.H., Marshall J. Tissue specific damage to the retinal pigment epithelium: mechanisms and therapeutic implications. Lasers Light Ophthalmol 1992, 5:17-28.
81. Sliney D.H., Wolbarsht M.L. Safety with Lasers Other Optical Sources 1980, Plenum Publishing Corp, New York.
82. Stayt J., Gillies M.C. TGF-b increases permeability of retinal capillary endothelial cell monolayers and is associated with tyrosine phosphorylation of intercellular proteins [ARVO abstract no. 3671]. Invest Ophthalmol Vis Sci 1997, 38(4):S791.
83. Trivino A., Ramirez J.M., Andres M.V., et al. Comparison between chorioretinal effects of the single-pulse versus micropulsed diode laser in pigmented rabbits. Lasers Light Ophthalmol 1997, 8:31-38.
84. Ulbig M.R., Arden G.B., Hamilton A.M. Color contrast sensitivity and pattern electroretinographic findings after diode and argon laser photocoagulation in diabetic retinopathy. Am J Ophthalmol 1994, 117:583-588.
85. Ulbig M.W., McHugh D.A., Hamilton A.M.P. Diode laser photocoagulation for diabetic macular oedema. Br J Ophthalmol 1995, 79:318-321.
86. Vogel A., Birngruber R. Temperature profiles in human retina and choroid during laser coagulation with different wavelengths ranging from 524 to 810 nm. Lasers Light Ophthalmol 1992, 5:9-16.
87. Wallow I.H.L., Bindley C.D. Focal photocoagulation of diabetic macular edema: a clinicopathologic case report. Retina 1988, 8:261-269.
88. Wang M.S., Sander B., Larsen M. Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 2002, 133:787-793.